Premium
Serum MUC‐1 as a marker of disease status in multiple myeloma patients receiving thalidomide – Response to mileshkin et al.
Author(s) -
Luminari Stefano,
Federico Massimo,
Baldini Luca
Publication year - 2003
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.2003.04678.x
Subject(s) - multiple myeloma , thalidomide , medicine , population , dexamethasone , gastroenterology , refractory (planetary science) , lactate dehydrogenase , disease , biochemistry , chemistry , physics , environmental health , astrobiology , enzyme